ArticleInternational journal of genomics2025

COL22A1 Activates the PI3K/AKT Signaling Pathway to Sustain the Malignancy of Glioblastoma.

Tao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.